nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP3A4—Ezetimibe—atherosclerosis	0.0911	0.211	CbGbCtD
Letrozole—CYP3A4—Rosuvastatin—atherosclerosis	0.0911	0.211	CbGbCtD
Letrozole—CYP3A4—Simvastatin—atherosclerosis	0.0847	0.196	CbGbCtD
Letrozole—CYP3A4—Pravastatin—atherosclerosis	0.0829	0.192	CbGbCtD
Letrozole—CYP3A4—Lovastatin—atherosclerosis	0.0829	0.192	CbGbCtD
Letrozole—CYP19A1—Endogenous sterols—CYP7A1—atherosclerosis	0.00309	0.0455	CbGpPWpGaD
Letrozole—CYP19A1—Endogenous sterols—CYP27A1—atherosclerosis	0.00286	0.0421	CbGpPWpGaD
Letrozole—CYP19A1—Ovarian Infertility Genes—GJA4—atherosclerosis	0.00262	0.0385	CbGpPWpGaD
Letrozole—CYP3A4—Liver X Receptor Pathway—ABCG8—atherosclerosis	0.00245	0.0361	CbGpPWpGaD
Letrozole—CYP3A4—Liver X Receptor Pathway—CYP7A1—atherosclerosis	0.00176	0.0259	CbGpPWpGaD
Letrozole—CYP3A4—Liver X Receptor Pathway—ABCG5—atherosclerosis	0.00152	0.0224	CbGpPWpGaD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.00144	0.0211	CbGpPWpGaD
Letrozole—Alopecia—Lovastatin—atherosclerosis	0.00143	0.00287	CcSEcCtD
Letrozole—Arthralgia—Rosuvastatin—atherosclerosis	0.00142	0.00284	CcSEcCtD
Letrozole—Myalgia—Rosuvastatin—atherosclerosis	0.00142	0.00284	CcSEcCtD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.00142	0.0209	CbGpPWpGaD
Letrozole—Flushing—Simvastatin—atherosclerosis	0.00141	0.00282	CcSEcCtD
Letrozole—Alopecia—Ezetimibe—atherosclerosis	0.0014	0.00281	CcSEcCtD
Letrozole—Haemoglobin—Niacin—atherosclerosis	0.0014	0.0028	CcSEcCtD
Letrozole—Mental disorder—Ezetimibe—atherosclerosis	0.00139	0.00279	CcSEcCtD
Letrozole—Haemorrhage—Niacin—atherosclerosis	0.00139	0.00279	CcSEcCtD
Letrozole—Hepatitis—Niacin—atherosclerosis	0.00139	0.00279	CcSEcCtD
Letrozole—Hypoaesthesia—Niacin—atherosclerosis	0.00139	0.00277	CcSEcCtD
Letrozole—Malnutrition—Ezetimibe—atherosclerosis	0.00138	0.00277	CcSEcCtD
Letrozole—Dysgeusia—Lovastatin—atherosclerosis	0.00138	0.00277	CcSEcCtD
Letrozole—Oedema peripheral—Niacin—atherosclerosis	0.00137	0.00275	CcSEcCtD
Letrozole—Hepatitis—Pravastatin—atherosclerosis	0.00137	0.00275	CcSEcCtD
Letrozole—Back pain—Lovastatin—atherosclerosis	0.00136	0.00273	CcSEcCtD
Letrozole—Hypoaesthesia—Pravastatin—atherosclerosis	0.00136	0.00273	CcSEcCtD
Letrozole—Infection—Rosuvastatin—atherosclerosis	0.00135	0.0027	CcSEcCtD
Letrozole—Alopecia—Simvastatin—atherosclerosis	0.00134	0.00268	CcSEcCtD
Letrozole—Back pain—Ezetimibe—atherosclerosis	0.00134	0.00268	CcSEcCtD
Letrozole—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00133	0.00267	CcSEcCtD
Letrozole—Vision blurred—Lovastatin—atherosclerosis	0.00133	0.00266	CcSEcCtD
Letrozole—Mental disorder—Simvastatin—atherosclerosis	0.00133	0.00266	CcSEcCtD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.00133	0.0195	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.00131	0.0193	CbGpPWpGaD
Letrozole—Ill-defined disorder—Lovastatin—atherosclerosis	0.00131	0.00262	CcSEcCtD
Letrozole—Eye disorder—Niacin—atherosclerosis	0.0013	0.00261	CcSEcCtD
Letrozole—Erythema multiforme—Pravastatin—atherosclerosis	0.0013	0.0026	CcSEcCtD
Letrozole—Dysgeusia—Simvastatin—atherosclerosis	0.00129	0.00259	CcSEcCtD
Letrozole—Flushing—Niacin—atherosclerosis	0.00129	0.00259	CcSEcCtD
Letrozole—Angioedema—Lovastatin—atherosclerosis	0.00129	0.00258	CcSEcCtD
Letrozole—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00128	0.00257	CcSEcCtD
Letrozole—Malaise—Lovastatin—atherosclerosis	0.00127	0.00255	CcSEcCtD
Letrozole—Cardiac disorder—Pravastatin—atherosclerosis	0.00127	0.00255	CcSEcCtD
Letrozole—Flushing—Pravastatin—atherosclerosis	0.00127	0.00255	CcSEcCtD
Letrozole—CYP19A1—Ovarian Infertility Genes—ESR2—atherosclerosis	0.00127	0.0187	CbGpPWpGaD
Letrozole—Vertigo—Lovastatin—atherosclerosis	0.00127	0.00254	CcSEcCtD
Letrozole—Angioedema—Ezetimibe—atherosclerosis	0.00126	0.00253	CcSEcCtD
Letrozole—Angiopathy—Niacin—atherosclerosis	0.00126	0.00253	CcSEcCtD
Letrozole—Leukopenia—Lovastatin—atherosclerosis	0.00126	0.00253	CcSEcCtD
Letrozole—Malaise—Ezetimibe—atherosclerosis	0.00125	0.0025	CcSEcCtD
Letrozole—Vision blurred—Simvastatin—atherosclerosis	0.00124	0.00249	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00124	0.00248	CcSEcCtD
Letrozole—Alopecia—Niacin—atherosclerosis	0.00123	0.00246	CcSEcCtD
Letrozole—Insomnia—Rosuvastatin—atherosclerosis	0.00123	0.00246	CcSEcCtD
Letrozole—Ill-defined disorder—Simvastatin—atherosclerosis	0.00122	0.00245	CcSEcCtD
Letrozole—Palpitations—Ezetimibe—atherosclerosis	0.00122	0.00245	CcSEcCtD
Letrozole—Paraesthesia—Rosuvastatin—atherosclerosis	0.00122	0.00244	CcSEcCtD
Letrozole—Malnutrition—Niacin—atherosclerosis	0.00121	0.00243	CcSEcCtD
Letrozole—Alopecia—Pravastatin—atherosclerosis	0.00121	0.00243	CcSEcCtD
Letrozole—Cough—Ezetimibe—atherosclerosis	0.00121	0.00242	CcSEcCtD
Letrozole—Angioedema—Simvastatin—atherosclerosis	0.00121	0.00242	CcSEcCtD
Letrozole—Myalgia—Lovastatin—atherosclerosis	0.0012	0.00241	CcSEcCtD
Letrozole—Arthralgia—Lovastatin—atherosclerosis	0.0012	0.00241	CcSEcCtD
Letrozole—Chest pain—Lovastatin—atherosclerosis	0.0012	0.00241	CcSEcCtD
Letrozole—Anxiety—Lovastatin—atherosclerosis	0.0012	0.0024	CcSEcCtD
Letrozole—Dyspepsia—Rosuvastatin—atherosclerosis	0.0012	0.0024	CcSEcCtD
Letrozole—Hypertension—Ezetimibe—atherosclerosis	0.00119	0.00239	CcSEcCtD
Letrozole—Malaise—Simvastatin—atherosclerosis	0.00119	0.00238	CcSEcCtD
Letrozole—Tension—Niacin—atherosclerosis	0.00119	0.00238	CcSEcCtD
Letrozole—Discomfort—Lovastatin—atherosclerosis	0.00119	0.00238	CcSEcCtD
Letrozole—Vertigo—Simvastatin—atherosclerosis	0.00119	0.00237	CcSEcCtD
Letrozole—Leukopenia—Simvastatin—atherosclerosis	0.00118	0.00237	CcSEcCtD
Letrozole—Myalgia—Ezetimibe—atherosclerosis	0.00118	0.00236	CcSEcCtD
Letrozole—Arthralgia—Ezetimibe—atherosclerosis	0.00118	0.00236	CcSEcCtD
Letrozole—Chest pain—Ezetimibe—atherosclerosis	0.00118	0.00236	CcSEcCtD
Letrozole—Nervousness—Niacin—atherosclerosis	0.00118	0.00236	CcSEcCtD
Letrozole—Dry mouth—Lovastatin—atherosclerosis	0.00117	0.00235	CcSEcCtD
Letrozole—Tension—Pravastatin—atherosclerosis	0.00117	0.00234	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00117	0.00234	CcSEcCtD
Letrozole—Dysgeusia—Pravastatin—atherosclerosis	0.00117	0.00234	CcSEcCtD
Letrozole—Discomfort—Ezetimibe—atherosclerosis	0.00116	0.00233	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.00116	0.0171	CbGpPWpGaD
Letrozole—Pain—Rosuvastatin—atherosclerosis	0.00116	0.00233	CcSEcCtD
Letrozole—Constipation—Rosuvastatin—atherosclerosis	0.00116	0.00233	CcSEcCtD
Letrozole—Nervousness—Pravastatin—atherosclerosis	0.00116	0.00232	CcSEcCtD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—atherosclerosis	0.00115	0.017	CbGpPWpGaD
Letrozole—Dry mouth—Ezetimibe—atherosclerosis	0.00115	0.00231	CcSEcCtD
Letrozole—Anaphylactic shock—Lovastatin—atherosclerosis	0.00115	0.00231	CcSEcCtD
Letrozole—CYP3A4—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.00115	0.0169	CbGpPWpGaD
Letrozole—Infection—Lovastatin—atherosclerosis	0.00114	0.00229	CcSEcCtD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.00114	0.0168	CbGpPWpGaD
Letrozole—Vision blurred—Niacin—atherosclerosis	0.00114	0.00229	CcSEcCtD
Letrozole—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00113	0.00226	CcSEcCtD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.00113	0.0166	CbGpPWpGaD
Letrozole—Vision blurred—Pravastatin—atherosclerosis	0.00112	0.00225	CcSEcCtD
Letrozole—Arthralgia—Simvastatin—atherosclerosis	0.00112	0.00225	CcSEcCtD
Letrozole—Myalgia—Simvastatin—atherosclerosis	0.00112	0.00225	CcSEcCtD
Letrozole—Chest pain—Simvastatin—atherosclerosis	0.00112	0.00225	CcSEcCtD
Letrozole—Infection—Ezetimibe—atherosclerosis	0.00112	0.00225	CcSEcCtD
Letrozole—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00112	0.00224	CcSEcCtD
Letrozole—Anxiety—Simvastatin—atherosclerosis	0.00112	0.00224	CcSEcCtD
Letrozole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00111	0.00223	CcSEcCtD
Letrozole—Discomfort—Simvastatin—atherosclerosis	0.00111	0.00222	CcSEcCtD
Letrozole—Nervous system disorder—Ezetimibe—atherosclerosis	0.00111	0.00222	CcSEcCtD
Letrozole—Angioedema—Niacin—atherosclerosis	0.00111	0.00222	CcSEcCtD
Letrozole—Ill-defined disorder—Pravastatin—atherosclerosis	0.00111	0.00222	CcSEcCtD
Letrozole—Anorexia—Lovastatin—atherosclerosis	0.0011	0.0022	CcSEcCtD
Letrozole—Skin disorder—Ezetimibe—atherosclerosis	0.0011	0.0022	CcSEcCtD
Letrozole—Angioedema—Pravastatin—atherosclerosis	0.00109	0.00218	CcSEcCtD
Letrozole—Vertigo—Niacin—atherosclerosis	0.00109	0.00218	CcSEcCtD
Letrozole—Leukopenia—Niacin—atherosclerosis	0.00108	0.00217	CcSEcCtD
Letrozole—Urticaria—Rosuvastatin—atherosclerosis	0.00108	0.00216	CcSEcCtD
Letrozole—Oedema—Simvastatin—atherosclerosis	0.00108	0.00216	CcSEcCtD
Letrozole—Anaphylactic shock—Simvastatin—atherosclerosis	0.00108	0.00216	CcSEcCtD
Letrozole—Malaise—Pravastatin—atherosclerosis	0.00108	0.00215	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.00108	0.0158	CbGpPWpGaD
Letrozole—Abdominal pain—Rosuvastatin—atherosclerosis	0.00107	0.00215	CcSEcCtD
Letrozole—Vertigo—Pravastatin—atherosclerosis	0.00107	0.00215	CcSEcCtD
Letrozole—Palpitations—Niacin—atherosclerosis	0.00107	0.00214	CcSEcCtD
Letrozole—Infection—Simvastatin—atherosclerosis	0.00107	0.00214	CcSEcCtD
Letrozole—Leukopenia—Pravastatin—atherosclerosis	0.00107	0.00214	CcSEcCtD
Letrozole—Cough—Niacin—atherosclerosis	0.00106	0.00212	CcSEcCtD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.00106	0.0155	CbGpPWpGaD
Letrozole—CYP3A4—Farnesoid X Receptor  Pathway—CYP7A1—atherosclerosis	0.00105	0.0155	CbGpPWpGaD
Letrozole—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00105	0.0021	CcSEcCtD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.00104	0.0153	CbGpPWpGaD
Letrozole—Insomnia—Lovastatin—atherosclerosis	0.00104	0.00209	CcSEcCtD
Letrozole—Cough—Pravastatin—atherosclerosis	0.00104	0.00209	CcSEcCtD
Letrozole—Paraesthesia—Lovastatin—atherosclerosis	0.00103	0.00207	CcSEcCtD
Letrozole—Myalgia—Niacin—atherosclerosis	0.00103	0.00207	CcSEcCtD
Letrozole—Arthralgia—Niacin—atherosclerosis	0.00103	0.00207	CcSEcCtD
Letrozole—Hypertension—Pravastatin—atherosclerosis	0.00103	0.00206	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00103	0.00206	CcSEcCtD
Letrozole—Anorexia—Simvastatin—atherosclerosis	0.00103	0.00206	CcSEcCtD
Letrozole—Dyspnoea—Lovastatin—atherosclerosis	0.00103	0.00206	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00102	0.00205	CcSEcCtD
Letrozole—Insomnia—Ezetimibe—atherosclerosis	0.00102	0.00205	CcSEcCtD
Letrozole—Arthralgia—Pravastatin—atherosclerosis	0.00102	0.00203	CcSEcCtD
Letrozole—Myalgia—Pravastatin—atherosclerosis	0.00102	0.00203	CcSEcCtD
Letrozole—Chest pain—Pravastatin—atherosclerosis	0.00102	0.00203	CcSEcCtD
Letrozole—Paraesthesia—Ezetimibe—atherosclerosis	0.00101	0.00203	CcSEcCtD
Letrozole—Dyspepsia—Lovastatin—atherosclerosis	0.00101	0.00203	CcSEcCtD
Letrozole—Anxiety—Pravastatin—atherosclerosis	0.00101	0.00203	CcSEcCtD
Letrozole—Dry mouth—Niacin—atherosclerosis	0.00101	0.00202	CcSEcCtD
Letrozole—Dyspnoea—Ezetimibe—atherosclerosis	0.00101	0.00202	CcSEcCtD
Letrozole—Discomfort—Pravastatin—atherosclerosis	0.001	0.00201	CcSEcCtD
Letrozole—Decreased appetite—Lovastatin—atherosclerosis	0.001	0.002	CcSEcCtD
Letrozole—Dyspepsia—Ezetimibe—atherosclerosis	0.000994	0.00199	CcSEcCtD
Letrozole—Fatigue—Lovastatin—atherosclerosis	0.000993	0.00199	CcSEcCtD
Letrozole—Oedema—Niacin—atherosclerosis	0.000989	0.00198	CcSEcCtD
Letrozole—Anaphylactic shock—Niacin—atherosclerosis	0.000989	0.00198	CcSEcCtD
Letrozole—Constipation—Lovastatin—atherosclerosis	0.000985	0.00197	CcSEcCtD
Letrozole—Pain—Lovastatin—atherosclerosis	0.000985	0.00197	CcSEcCtD
Letrozole—Decreased appetite—Ezetimibe—atherosclerosis	0.000982	0.00197	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000981	0.00197	CcSEcCtD
Letrozole—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000975	0.00195	CcSEcCtD
Letrozole—Asthenia—Rosuvastatin—atherosclerosis	0.000975	0.00195	CcSEcCtD
Letrozole—Insomnia—Simvastatin—atherosclerosis	0.000974	0.00195	CcSEcCtD
Letrozole—Oedema—Pravastatin—atherosclerosis	0.000974	0.00195	CcSEcCtD
Letrozole—Anaphylactic shock—Pravastatin—atherosclerosis	0.000974	0.00195	CcSEcCtD
Letrozole—Fatigue—Ezetimibe—atherosclerosis	0.000974	0.00195	CcSEcCtD
Letrozole—Infection—Pravastatin—atherosclerosis	0.000967	0.00194	CcSEcCtD
Letrozole—Paraesthesia—Simvastatin—atherosclerosis	0.000967	0.00194	CcSEcCtD
Letrozole—Constipation—Ezetimibe—atherosclerosis	0.000966	0.00193	CcSEcCtD
Letrozole—Pain—Ezetimibe—atherosclerosis	0.000966	0.00193	CcSEcCtD
Letrozole—Tachycardia—Niacin—atherosclerosis	0.000965	0.00193	CcSEcCtD
Letrozole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.000965	0.0142	CbGpPWpGaD
Letrozole—Pruritus—Rosuvastatin—atherosclerosis	0.000961	0.00193	CcSEcCtD
Letrozole—Skin disorder—Niacin—atherosclerosis	0.000961	0.00192	CcSEcCtD
Letrozole—Dyspnoea—Simvastatin—atherosclerosis	0.00096	0.00192	CcSEcCtD
Letrozole—Hyperhidrosis—Niacin—atherosclerosis	0.000956	0.00191	CcSEcCtD
Letrozole—Feeling abnormal—Lovastatin—atherosclerosis	0.000949	0.0019	CcSEcCtD
Letrozole—Dyspepsia—Simvastatin—atherosclerosis	0.000948	0.0019	CcSEcCtD
Letrozole—Anorexia—Niacin—atherosclerosis	0.000943	0.00189	CcSEcCtD
Letrozole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000942	0.00189	CcSEcCtD
Letrozole—Hyperhidrosis—Pravastatin—atherosclerosis	0.000941	0.00189	CcSEcCtD
Letrozole—Decreased appetite—Simvastatin—atherosclerosis	0.000936	0.00188	CcSEcCtD
Letrozole—Feeling abnormal—Ezetimibe—atherosclerosis	0.000931	0.00186	CcSEcCtD
Letrozole—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00093	0.00186	CcSEcCtD
Letrozole—Diarrhoea—Rosuvastatin—atherosclerosis	0.00093	0.00186	CcSEcCtD
Letrozole—Fatigue—Simvastatin—atherosclerosis	0.000929	0.00186	CcSEcCtD
Letrozole—Anorexia—Pravastatin—atherosclerosis	0.000928	0.00186	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000926	0.0136	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000924	0.00185	CcSEcCtD
Letrozole—Constipation—Simvastatin—atherosclerosis	0.000921	0.00184	CcSEcCtD
Letrozole—Pain—Simvastatin—atherosclerosis	0.000921	0.00184	CcSEcCtD
Letrozole—Urticaria—Lovastatin—atherosclerosis	0.000915	0.00183	CcSEcCtD
Letrozole—Body temperature increased—Lovastatin—atherosclerosis	0.00091	0.00182	CcSEcCtD
Letrozole—Abdominal pain—Lovastatin—atherosclerosis	0.00091	0.00182	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000901	0.0018	CcSEcCtD
Letrozole—Dizziness—Rosuvastatin—atherosclerosis	0.000899	0.0018	CcSEcCtD
Letrozole—Urticaria—Ezetimibe—atherosclerosis	0.000897	0.0018	CcSEcCtD
Letrozole—Insomnia—Niacin—atherosclerosis	0.000895	0.00179	CcSEcCtD
Letrozole—Body temperature increased—Ezetimibe—atherosclerosis	0.000893	0.00179	CcSEcCtD
Letrozole—Abdominal pain—Ezetimibe—atherosclerosis	0.000893	0.00179	CcSEcCtD
Letrozole—Paraesthesia—Niacin—atherosclerosis	0.000888	0.00178	CcSEcCtD
Letrozole—Feeling abnormal—Simvastatin—atherosclerosis	0.000888	0.00178	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000887	0.00178	CcSEcCtD
Letrozole—Dyspnoea—Niacin—atherosclerosis	0.000882	0.00177	CcSEcCtD
Letrozole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000881	0.00176	CcSEcCtD
Letrozole—Insomnia—Pravastatin—atherosclerosis	0.000881	0.00176	CcSEcCtD
Letrozole—Somnolence—Niacin—atherosclerosis	0.000879	0.00176	CcSEcCtD
Letrozole—Paraesthesia—Pravastatin—atherosclerosis	0.000874	0.00175	CcSEcCtD
Letrozole—Dyspepsia—Niacin—atherosclerosis	0.000871	0.00174	CcSEcCtD
Letrozole—Dyspnoea—Pravastatin—atherosclerosis	0.000868	0.00174	CcSEcCtD
Letrozole—Decreased appetite—Niacin—atherosclerosis	0.00086	0.00172	CcSEcCtD
Letrozole—Dyspepsia—Pravastatin—atherosclerosis	0.000857	0.00172	CcSEcCtD
Letrozole—Rash—Rosuvastatin—atherosclerosis	0.000857	0.00172	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000856	0.0126	CbGpPWpGaD
Letrozole—Dermatitis—Rosuvastatin—atherosclerosis	0.000856	0.00171	CcSEcCtD
Letrozole—Urticaria—Simvastatin—atherosclerosis	0.000856	0.00171	CcSEcCtD
Letrozole—Gastrointestinal disorder—Niacin—atherosclerosis	0.000854	0.00171	CcSEcCtD
Letrozole—Abdominal pain—Simvastatin—atherosclerosis	0.000852	0.00171	CcSEcCtD
Letrozole—Body temperature increased—Simvastatin—atherosclerosis	0.000852	0.00171	CcSEcCtD
Letrozole—Headache—Rosuvastatin—atherosclerosis	0.000851	0.0017	CcSEcCtD
Letrozole—Decreased appetite—Pravastatin—atherosclerosis	0.000847	0.0017	CcSEcCtD
Letrozole—Pain—Niacin—atherosclerosis	0.000846	0.00169	CcSEcCtD
Letrozole—Fatigue—Pravastatin—atherosclerosis	0.00084	0.00168	CcSEcCtD
Letrozole—Pain—Pravastatin—atherosclerosis	0.000833	0.00167	CcSEcCtD
Letrozole—Constipation—Pravastatin—atherosclerosis	0.000833	0.00167	CcSEcCtD
Letrozole—Asthenia—Lovastatin—atherosclerosis	0.000826	0.00165	CcSEcCtD
Letrozole—Pruritus—Lovastatin—atherosclerosis	0.000815	0.00163	CcSEcCtD
Letrozole—Asthenia—Ezetimibe—atherosclerosis	0.00081	0.00162	CcSEcCtD
Letrozole—Gastrointestinal pain—Niacin—atherosclerosis	0.000809	0.00162	CcSEcCtD
Letrozole—Nausea—Rosuvastatin—atherosclerosis	0.000807	0.00162	CcSEcCtD
Letrozole—Feeling abnormal—Pravastatin—atherosclerosis	0.000803	0.00161	CcSEcCtD
Letrozole—Pruritus—Ezetimibe—atherosclerosis	0.000799	0.0016	CcSEcCtD
Letrozole—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000796	0.00159	CcSEcCtD
Letrozole—Diarrhoea—Lovastatin—atherosclerosis	0.000788	0.00158	CcSEcCtD
Letrozole—Urticaria—Niacin—atherosclerosis	0.000786	0.00157	CcSEcCtD
Letrozole—Body temperature increased—Niacin—atherosclerosis	0.000782	0.00157	CcSEcCtD
Letrozole—Abdominal pain—Niacin—atherosclerosis	0.000782	0.00157	CcSEcCtD
Letrozole—Urticaria—Pravastatin—atherosclerosis	0.000774	0.00155	CcSEcCtD
Letrozole—Asthenia—Simvastatin—atherosclerosis	0.000773	0.00155	CcSEcCtD
Letrozole—Diarrhoea—Ezetimibe—atherosclerosis	0.000773	0.00155	CcSEcCtD
Letrozole—Abdominal pain—Pravastatin—atherosclerosis	0.00077	0.00154	CcSEcCtD
Letrozole—Body temperature increased—Pravastatin—atherosclerosis	0.00077	0.00154	CcSEcCtD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—atherosclerosis	0.000766	0.0113	CbGpPWpGaD
Letrozole—Pruritus—Simvastatin—atherosclerosis	0.000762	0.00153	CcSEcCtD
Letrozole—Dizziness—Lovastatin—atherosclerosis	0.000762	0.00153	CcSEcCtD
Letrozole—Dizziness—Ezetimibe—atherosclerosis	0.000747	0.0015	CcSEcCtD
Letrozole—Diarrhoea—Simvastatin—atherosclerosis	0.000737	0.00148	CcSEcCtD
Letrozole—Vomiting—Lovastatin—atherosclerosis	0.000732	0.00147	CcSEcCtD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000728	0.0107	CbGpPWpGaD
Letrozole—Rash—Lovastatin—atherosclerosis	0.000726	0.00145	CcSEcCtD
Letrozole—Dermatitis—Lovastatin—atherosclerosis	0.000725	0.00145	CcSEcCtD
Letrozole—Headache—Lovastatin—atherosclerosis	0.000721	0.00144	CcSEcCtD
Letrozole—Vomiting—Ezetimibe—atherosclerosis	0.000718	0.00144	CcSEcCtD
Letrozole—Dizziness—Simvastatin—atherosclerosis	0.000712	0.00143	CcSEcCtD
Letrozole—Rash—Ezetimibe—atherosclerosis	0.000712	0.00143	CcSEcCtD
Letrozole—Dermatitis—Ezetimibe—atherosclerosis	0.000712	0.00142	CcSEcCtD
Letrozole—Asthenia—Niacin—atherosclerosis	0.00071	0.00142	CcSEcCtD
Letrozole—Headache—Ezetimibe—atherosclerosis	0.000708	0.00142	CcSEcCtD
Letrozole—Pruritus—Niacin—atherosclerosis	0.0007	0.0014	CcSEcCtD
Letrozole—Asthenia—Pravastatin—atherosclerosis	0.000699	0.0014	CcSEcCtD
Letrozole—Pruritus—Pravastatin—atherosclerosis	0.000689	0.00138	CcSEcCtD
Letrozole—Vomiting—Simvastatin—atherosclerosis	0.000685	0.00137	CcSEcCtD
Letrozole—Nausea—Lovastatin—atherosclerosis	0.000684	0.00137	CcSEcCtD
Letrozole—Rash—Simvastatin—atherosclerosis	0.000679	0.00136	CcSEcCtD
Letrozole—Dermatitis—Simvastatin—atherosclerosis	0.000679	0.00136	CcSEcCtD
Letrozole—Diarrhoea—Niacin—atherosclerosis	0.000677	0.00136	CcSEcCtD
Letrozole—Headache—Simvastatin—atherosclerosis	0.000675	0.00135	CcSEcCtD
Letrozole—CYP2A6—Fluoropyrimidine Activity—MTHFR—atherosclerosis	0.000673	0.0099	CbGpPWpGaD
Letrozole—Nausea—Ezetimibe—atherosclerosis	0.000671	0.00134	CcSEcCtD
Letrozole—Diarrhoea—Pravastatin—atherosclerosis	0.000666	0.00133	CcSEcCtD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—atherosclerosis	0.000665	0.00978	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.00066	0.00971	CbGpPWpGaD
Letrozole—Dizziness—Niacin—atherosclerosis	0.000654	0.00131	CcSEcCtD
Letrozole—Dizziness—Pravastatin—atherosclerosis	0.000644	0.00129	CcSEcCtD
Letrozole—Nausea—Simvastatin—atherosclerosis	0.00064	0.00128	CcSEcCtD
Letrozole—Vomiting—Niacin—atherosclerosis	0.000629	0.00126	CcSEcCtD
Letrozole—Rash—Niacin—atherosclerosis	0.000624	0.00125	CcSEcCtD
Letrozole—Dermatitis—Niacin—atherosclerosis	0.000623	0.00125	CcSEcCtD
Letrozole—Headache—Niacin—atherosclerosis	0.00062	0.00124	CcSEcCtD
Letrozole—Vomiting—Pravastatin—atherosclerosis	0.000619	0.00124	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—CYP7A1—atherosclerosis	0.000618	0.0091	CbGpPWpGaD
Letrozole—Rash—Pravastatin—atherosclerosis	0.000614	0.00123	CcSEcCtD
Letrozole—Dermatitis—Pravastatin—atherosclerosis	0.000613	0.00123	CcSEcCtD
Letrozole—Headache—Pravastatin—atherosclerosis	0.00061	0.00122	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—CYP7A1—atherosclerosis	0.00061	0.00897	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—atherosclerosis	0.000603	0.00888	CbGpPWpGaD
Letrozole—Nausea—Niacin—atherosclerosis	0.000588	0.00118	CcSEcCtD
Letrozole—Nausea—Pravastatin—atherosclerosis	0.000578	0.00116	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—CYP27A1—atherosclerosis	0.000571	0.00841	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000571	0.00841	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000564	0.0083	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AHR—atherosclerosis	0.000525	0.00772	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP7A1—atherosclerosis	0.000492	0.00724	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—MAPK3—atherosclerosis	0.000472	0.00694	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP27A1—atherosclerosis	0.000455	0.00669	CbGpPWpGaD
Letrozole—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000453	0.00667	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000419	0.00617	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000413	0.00609	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000406	0.00598	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—HMGCR—atherosclerosis	0.000398	0.00585	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000387	0.0057	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000382	0.00562	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000382	0.00562	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000341	0.00502	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.00034	0.005	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000331	0.00488	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000331	0.00488	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—AKT1—atherosclerosis	0.000318	0.00468	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000314	0.00462	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—atherosclerosis	0.000295	0.00435	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000262	0.00385	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—GSTM1—atherosclerosis	0.000255	0.00376	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—GSTM1—atherosclerosis	0.000252	0.00371	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—HMOX1—atherosclerosis	0.000249	0.00366	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000246	0.00362	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000246	0.00362	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000242	0.00356	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—atherosclerosis	0.000241	0.00354	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000237	0.00349	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000236	0.00348	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—GSTM1—atherosclerosis	0.000232	0.00341	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—AGER—atherosclerosis	0.000223	0.00329	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—atherosclerosis	0.000223	0.00327	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000219	0.00323	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000208	0.00306	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000208	0.00306	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000208	0.00306	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000208	0.00306	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000205	0.00302	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—GSTM1—atherosclerosis	0.000203	0.00299	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—PDGFB—atherosclerosis	0.000199	0.00293	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000198	0.00292	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000195	0.00287	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00019	0.0028	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000183	0.0027	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LDLRAP1—atherosclerosis	0.000181	0.00266	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.00018	0.00266	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000178	0.00262	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000177	0.0026	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PLTP—atherosclerosis	0.00017	0.0025	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.000167	0.00245	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000164	0.00242	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000158	0.00232	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000157	0.00231	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000156	0.00229	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000152	0.00224	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCG8—atherosclerosis	0.000148	0.00217	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LTA4H—atherosclerosis	0.000148	0.00217	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000146	0.00214	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LDLRAP1—atherosclerosis	0.000144	0.00212	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	0.000139	0.00204	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000138	0.00202	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PLTP—atherosclerosis	0.000135	0.00199	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	0.000126	0.00185	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000123	0.0018	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCG8—atherosclerosis	0.000117	0.00173	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LTA4H—atherosclerosis	0.000117	0.00173	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCG1—atherosclerosis	0.000117	0.00172	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LCAT—atherosclerosis	0.00011	0.00161	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—FABP4—atherosclerosis	0.00011	0.00161	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOA4—atherosclerosis	0.000108	0.00158	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP7A1—atherosclerosis	0.000106	0.00156	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000101	0.00148	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP27A1—atherosclerosis	9.77e-05	0.00144	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	9.62e-05	0.00142	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—TGFB1—atherosclerosis	9.44e-05	0.00139	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	9.39e-05	0.00138	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCG1—atherosclerosis	9.28e-05	0.00137	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOA2—atherosclerosis	9.26e-05	0.00136	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALOX5AP—atherosclerosis	9.26e-05	0.00136	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALOX15—atherosclerosis	9.26e-05	0.00136	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PLA2G2A—atherosclerosis	9.26e-05	0.00136	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCG5—atherosclerosis	9.15e-05	0.00135	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	9.14e-05	0.00135	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LPA—atherosclerosis	8.84e-05	0.0013	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LCAT—atherosclerosis	8.73e-05	0.00128	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—FABP4—atherosclerosis	8.73e-05	0.00128	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOA4—atherosclerosis	8.57e-05	0.00126	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—BGN—atherosclerosis	8.56e-05	0.00126	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.5e-05	0.00125	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOA5—atherosclerosis	8.47e-05	0.00125	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP7A1—atherosclerosis	8.42e-05	0.00124	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.23e-05	0.00121	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PLA2G1B—atherosclerosis	8.16e-05	0.0012	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.06e-05	0.00119	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	8.03e-05	0.00118	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.99e-05	0.00118	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.97e-05	0.00117	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALOX5—atherosclerosis	7.88e-05	0.00116	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP27A1—atherosclerosis	7.78e-05	0.00114	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	7.45e-05	0.0011	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PLA2G2A—atherosclerosis	7.37e-05	0.00109	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOA2—atherosclerosis	7.37e-05	0.00109	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALOX15—atherosclerosis	7.37e-05	0.00109	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALOX5AP—atherosclerosis	7.37e-05	0.00109	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	7.35e-05	0.00108	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCG5—atherosclerosis	7.28e-05	0.00107	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.28e-05	0.00107	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NAMPT—atherosclerosis	7.07e-05	0.00104	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LPA—atherosclerosis	7.04e-05	0.00104	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.02e-05	0.00103	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LIPC—atherosclerosis	7.02e-05	0.00103	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOC3—atherosclerosis	6.98e-05	0.00103	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LDLR—atherosclerosis	6.94e-05	0.00102	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—BGN—atherosclerosis	6.81e-05	0.001	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CETP—atherosclerosis	6.77e-05	0.000997	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOA5—atherosclerosis	6.74e-05	0.000993	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PLA2G1B—atherosclerosis	6.49e-05	0.000955	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SCARB1—atherosclerosis	6.49e-05	0.000955	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.32e-05	0.00093	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALOX5—atherosclerosis	6.27e-05	0.000923	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HMGCR—atherosclerosis	6.13e-05	0.000902	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NAMPT—atherosclerosis	5.62e-05	0.000828	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LIPC—atherosclerosis	5.59e-05	0.000823	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOC3—atherosclerosis	5.55e-05	0.000817	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.53e-05	0.000813	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LDLR—atherosclerosis	5.52e-05	0.000812	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCA1—atherosclerosis	5.46e-05	0.000804	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CETP—atherosclerosis	5.39e-05	0.000794	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	5.28e-05	0.000777	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SCARB1—atherosclerosis	5.16e-05	0.00076	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PLTP—atherosclerosis	4.97e-05	0.000731	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMGCR—atherosclerosis	4.88e-05	0.000718	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HMOX1—atherosclerosis	4.68e-05	0.000689	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOB—atherosclerosis	4.49e-05	0.00066	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTM1—atherosclerosis	4.37e-05	0.000642	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCA1—atherosclerosis	4.35e-05	0.00064	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCG8—atherosclerosis	4.31e-05	0.000634	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LTA4H—atherosclerosis	4.31e-05	0.000634	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LPL—atherosclerosis	4.28e-05	0.000631	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GPX1—atherosclerosis	4.18e-05	0.000615	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CD36—atherosclerosis	4.07e-05	0.000599	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTHFR—atherosclerosis	3.86e-05	0.000568	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARA—atherosclerosis	3.78e-05	0.000557	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMOX1—atherosclerosis	3.73e-05	0.000549	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AGT—atherosclerosis	3.67e-05	0.000539	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOE—atherosclerosis	3.59e-05	0.000529	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOB—atherosclerosis	3.57e-05	0.000526	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CAV1—atherosclerosis	3.56e-05	0.000524	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOA1—atherosclerosis	3.55e-05	0.000523	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTM1—atherosclerosis	3.47e-05	0.000511	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LPL—atherosclerosis	3.41e-05	0.000502	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCG1—atherosclerosis	3.4e-05	0.000501	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GPX1—atherosclerosis	3.33e-05	0.00049	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CG—atherosclerosis	3.24e-05	0.000477	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CD36—atherosclerosis	3.24e-05	0.000477	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—FABP4—atherosclerosis	3.2e-05	0.000471	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LCAT—atherosclerosis	3.2e-05	0.000471	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOA4—atherosclerosis	3.14e-05	0.000462	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARG—atherosclerosis	3.13e-05	0.00046	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.09e-05	0.000454	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MTHFR—atherosclerosis	3.07e-05	0.000452	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—INS—atherosclerosis	3.07e-05	0.000452	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARA—atherosclerosis	3.01e-05	0.000443	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AGT—atherosclerosis	2.92e-05	0.000429	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOE—atherosclerosis	2.86e-05	0.000421	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.85e-05	0.00042	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CAV1—atherosclerosis	2.83e-05	0.000417	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOA1—atherosclerosis	2.83e-05	0.000416	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALB—atherosclerosis	2.81e-05	0.000414	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.7e-05	0.000398	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.7e-05	0.000398	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOA2—atherosclerosis	2.7e-05	0.000398	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.7e-05	0.000398	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NOS3—atherosclerosis	2.69e-05	0.000396	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.67e-05	0.000393	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CG—atherosclerosis	2.58e-05	0.00038	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LPA—atherosclerosis	2.58e-05	0.00038	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—BGN—atherosclerosis	2.5e-05	0.000368	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARG—atherosclerosis	2.49e-05	0.000366	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOA5—atherosclerosis	2.47e-05	0.000364	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS2—atherosclerosis	2.46e-05	0.000362	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—INS—atherosclerosis	2.44e-05	0.000359	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.38e-05	0.00035	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.3e-05	0.000338	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALB—atherosclerosis	2.24e-05	0.00033	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NOS3—atherosclerosis	2.14e-05	0.000315	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.06e-05	0.000303	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LIPC—atherosclerosis	2.05e-05	0.000302	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOC3—atherosclerosis	2.04e-05	0.0003	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LDLR—atherosclerosis	2.02e-05	0.000298	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CETP—atherosclerosis	1.98e-05	0.000291	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS2—atherosclerosis	1.96e-05	0.000288	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.89e-05	0.000279	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.79e-05	0.000263	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.59e-05	0.000235	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.37e-05	0.000201	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOB—atherosclerosis	1.31e-05	0.000193	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.27e-05	0.000187	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LPL—atherosclerosis	1.25e-05	0.000184	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—atherosclerosis	1.24e-05	0.000182	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GPX1—atherosclerosis	1.22e-05	0.00018	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CD36—atherosclerosis	1.19e-05	0.000175	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.13e-05	0.000166	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARA—atherosclerosis	1.1e-05	0.000163	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AGT—atherosclerosis	1.07e-05	0.000157	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOE—atherosclerosis	1.05e-05	0.000154	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CAV1—atherosclerosis	1.04e-05	0.000153	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOA1—atherosclerosis	1.04e-05	0.000152	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—atherosclerosis	9.84e-06	0.000145	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CG—atherosclerosis	9.46e-06	0.000139	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARG—atherosclerosis	9.13e-06	0.000134	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—INS—atherosclerosis	8.95e-06	0.000132	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALB—atherosclerosis	8.21e-06	0.000121	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NOS3—atherosclerosis	7.85e-06	0.000116	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS2—atherosclerosis	7.18e-06	0.000106	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—atherosclerosis	3.61e-06	5.31e-05	CbGpPWpGaD
